|
⚲
|
| Keyboard |
| Kkr Hcsg GP LLC | |
|---|---|
| Firm | Kohlberg Kravis Roberts & Co LP |
| Address | 9 West 57th Street Suite 4200 New York, NY 10019 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co LP | |||||
| KKR HCS Growth Fund SBS LP | 021-275494 | Promoter | 70.0 M | ||
| KKR Health Care Strategic Growth Fund LP | 021-275470 | Promoter | 334.0 M | 1,845.4 M | |
| KKR HCS Growth Fund ESC LP | 021-275487 | Promoter | |||
| Related People Network |
|---|
| Network #10 at Kohlberg Kravis Roberts & Co LP — files alongside 3 co-filers |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
IPI Legacy Liquidation Co IMPL
Common Stock
|
2021-04-27 | Other | 118,712 | $13.50 | 1,602,612 |
|
IPI Legacy Liquidation Co IMPL
Common Stock
|
2021-04-27 | Conversion | 2,583,926 | ||
|
IPI Legacy Liquidation Co IMPL
Common Stock
|
2021-04-27 | Buy | 1,100,000 | $15.00 | 16,500,000 |
|
IPI Legacy Liquidation Co IMPL
Series D Preferred Stock · derivative
|
2021-04-27 | Conversion | 42,307,448 | ||
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2019-11-04 | Conversion | 884,622 | ||
|
Oyster Point Pharma Inc OYST
Series B Convertible Preferred Stock · derivative
|
2019-11-04 | Conversion | 884,622 | ||
|
Oyster Point Pharma Inc OYST
Common Stock, par value $0.001 per share
|
2019-11-04 | Buy | 155,000 | $16.00 | 2,480,000 |